Rebalancing the depressed brain: a wholebrain computational study on the effects of external perturbations in psilocybin and escitalopram treatments

Full item page Simple item page

• dc.contributor.author Socoró Garrigosa, Marcel
• dc.date.accessioned 2025-03-05T11:30:19Z
• dc.date.available 2025-03-05T11:30:19Z
• dc.date.issued 2024
• dc.description Treball de Fi de Grau en Enginyeria Biomèdica. Curs 2023-2024
• dc.description Tutors: Gustavo Deco i Jakub Vohryzek
• dc.description.abstract Serotonergic psychedelics like psilocybin have been proposed as a promising avenue in the treatment of major depressive disorder (MDD). Contrary to selective serotonin reuptake inhibitors (SSRI) like escitalopram, psychedelics work through 5-HT2AR agonism, which opens a window of plasticity for psychotherapy- or neurostimulation-combined therapies. Here, we used a trial comparing psilocybin and escitalopram treatments for MDD to assess in silico the effect of external perturbations after pharmacological intervention. The trial included resting state fMRI scans before and one day after treatment. We built whole-brain models by fitting the data to capture the underlying causal brain mechanisms in generative effective connectivity. Then, we applied a perturbation protocol following the Dynamic Sensitivity Analysis paradigm, simulating the effects of external stimulations in parcellated regions. We evaluated the impact of perturbations by assessing regional susceptibility to change and effectivity to drive a healthy transition (both defined using static functional connectivity). We show that susceptibility is enhanced by psilocybin and reduced by escitalopram, evidencing an opening of a window of plasticity by psilocybin. However, healthy transitions are similarly achieved after both treatments, suggesting that escitalopram manages to improve perturbation effects despite differences in functional hierarchies compared to psilocybin. We elaborate that longer-term data and measures capturing the temporal richness of functional repertoires might be needed to complement these findings. Finally, we demonstrate the benefits of multi-site versus single-site perturbations and that the amygdala and the nucleus accumbens are the best perturbation targets to drive healthy transitions. Overall, the present work contributes to prior knowledge on how in silico perturbations can help in the treatment of MDD, serving as a foundation for larger computational studies.
• dc.identifier.uri http://hdl.handle.net/10230/69830
• dc.language.iso eng
• dc.rights © Tots els drets reservats
• dc.rights.accessRights info:eu-repo/semantics/openAccess
• dc.subject.keyword Depression
• dc.subject.keyword Functional magnetic resonance imaging
• dc.subject.keyword Whole-brain modelling
• dc.subject.keyword Dynamic sensitivity analysis
• dc.subject.keyword Neurostimulation
• dc.subject.keyword Psychedelics
• dc.subject.other Treball de fi de grau – Curs 2023-2024
• dc.title Rebalancing the depressed brain: a wholebrain computational study on the effects of external perturbations in psilocybin and escitalopram treatments
• dc.type info:eu-repo/semantics/bachelorThesis